and length of trocar incision, trauma caused by cholecystectomy itself, type of gas. Postoperative (PO) pain in turn affects postoperative morbidity, hospital stay, increased financial burden on the patient or the state due to increased duration of hospitalisation and inability of the patient to return to his/her job in time.
A number of studies have been done till date to try to assess the effectiveness of different measures to alleviate the PO operative pain after LC. PO pain management has an important role in preventing the postoperative morbidly and its consequences. Pain management has not been standardised at most medical centres in India and abroad and this is reflected in the number of different pain studies after LC available in literature. Analgesia provided before a noxious stimulus, known as pre emptive analgesia, may prevent physiologic changes, resulting in central sensitization and amplification of pain signals. Pre-emptive local anaesthesia, therefore, may be more effective than postoperative anaesthesia administration at preventing postoperative pain. Many experimental and clinical studies have demonstrated the inhibitory effect of pre-emptive analgesia on the development posttraumatic hyperalgesia, resulting in reduced postoperative pain and total analgesic requirements. [1] [2] [3] [4] Many different methods have been used with conflicting rates of success, to diminish the intensity of PO pain after LC. They include low pressure pneumoperitoneum, gasless technique of LC, use of warm carbon dioxide, peritoneal wash with saline solution, strict surgical technique, perfect haemostasis, trocar site infiltration of anaesthetic drugs, instillation of sub-diaphragmatic region with anaesthetic/analgesic drugs or use of non steroidal anti-inflammatory drugs or dexamethasone. Intensity of pain is also depent on timing of using various type of techniques. [5] [6] [7] Bupivacaine is the most consistently used in studies, typically at a concentration of 0.5%. To gain a major insight into the effectiveness of pre-emptive intraperitoneal and port site infiltration of Bupivacaine in postoperative pain relief after laparoscopic Cholecystectomy. [8] [9] [10] [11] [12] Bupivacaine is also used in comparison study to test its effectiveness in relieving pain after LC with intravenous analgesics as well saline washing of peritoneum. 13, 14 The present study was carried out in the Department of Surgery Medical College & Sir Sayajirao General Hospital. We hoped to establish conclusive evidence about the efficacy of pre-emptive infiltration of Bupivacaine over infiltration after gall bladder removal and whether one was superior to the other for pain relief. To assess the effectiveness of 0.5% of Bupivacaine for pain control after laparoscopic cholecystectomy (LC) at its optimal dose (2 mg/kg) by intra peritoneal instillation of Bupivacaine with infiltration at each trocar site before dissection of gall bladder. To establish whether either of this procedure is superior to other.
METHODS
A prospective, randomized study of 264 patients of benign Gall bladder disease in whom laparoscopic Cholecystectomy (LC) was conducted in the department of General Surgery at the Sir Sayajirao General Hospital & Medical College Baroda during a period of 25 months from October 2010 to October 2012 In all the cases a detail history, physical examination and investigations were done as per Proforma.
Inclusion criteria
Patients with age >18 years, ASA grade 1 or 2 (American Society of Anaesthesiology) and patients. Posted for elective laparoscopic Cholecystectomy were included in study.
Exclusion criteria
Patients with age <18 years, ASA Grade more than 2 (American Society of Anaesthesiology), pregnancy, acute cholecystitis, choledocholithiasis, conversion of LC to open cholecystectomy, patients allergic to local anesthesia, History of severe systemic disease, After taking informed and written consent, patients were randomized in three groups.
Randomization was done with prepared close enveloped. The day of operation an independent hospital staff randomly opened an envelope with a card in side. Patients were randomized to their respective card group, either "A", or "B".
Group "A" received 2 mg/kg of bupivacaine in 40 ml of saline from which 5 ml infiltration at each trocar site before skin incision, 20 ml of the drug instill under right sub diaphragmatic space, 20 ml of the drug instill over gall bladder through right sub costal trocar incision with 10 cc syringe before dissection of GB Group "B" received 2 mg/kg of Bupivacaine in 40ml of saline from which, 20 ml of the drug instill in gall bladder fosse through right sub costal trocar incision with 10cc syringe after removal of GB, 20 ml of the drug instill under right sub diaphragmatic space, 5ml at each trocar site after removal of GB
Pre-operative preparation
All patients coming to the Surgical Out-PatientDepartment (OPD) with benign Gall Bladder disease were admitted to surgical ward 2 to 3 days before the laparoscopic cholecystectomy. For all patients undergoing laparoscopic Cholecystectomy following preoperative preparation was done. Abdominal ultrasonography, X-ray chest, ECG, complete blood 
Technique of laparoscopic cholecystectomy
A fully informed written consent was taken informing about the laparoscopic procedure, its complications and the need, if necessary for conversion to open cholecystectomy. In all patients undergoing laparoscopic cholecystectomy of inj. Cefotaxime (1 gm) was given preoperatively. General anaesthesia was given to all the patient with routine pre medication. Patient was placed in supine position with 150 head tilt which improves diaphragmatic function and respiratory status. Catheterization was done if the bladder was found to be full. Pneumoperitoneum was created either open or closed method according to surgeon preference and gall bladder was dissected out from its bed by blunt and sharp dissection and was removed either from subcostal or umbillical port according to surgeon"s preference. Assessment of the nature of pain was done (visceral, parietal or shoulder pain) & its intensity was recorded on VAS (visual Analogue scale) after 4 hrs, 8 hrs & 24 hrs of surgery.
The VAS was a 10 mm horizontal scale representing varying intensities of pain, with end points labelled as ""no pain"" and ""worst possible pain." VAS scale was explained to the patient preoperatively. 
Statistical analysis
Continuous data between the two groups were recorded as mean±standard deviation and compared by the nonparametric Mann whiteny U test. A p<0.05 was considered statistically significant. All statistical analyses were performed by using SPSS 17.0 software for Windows.
RESULTS
A prospective, randomized study of 264 patients of benign gall bladder disease in whom laparoscopic cholecystectomy (LC) was conducted in the department of General Surgery at the Sir Sayajirao General Hospital & Medical College Baroda during a period of 25 months from October 2010 to October 2012. A total of 264 patients were included in this study. The total patient population included 195 females and 69 males.
Demographic and operative details of analysed data
Out of the 264 patients 74% of the patients were females and 26% were males. There were 69 males and 195 females for data analysis. The mean age of the 88 patients analysed was 45.96 years±11.48 SD. There was no significant difference between the groups with regard to age. There was no significant difference between the three groups as regards to body weight of the patients operated. Distribution of the patients as per the ASA was similar across both the groups.
Intra-peritoneal drain
In Group A only 15 patients out of 132 required intraperitoneal drain placement, in Group B it was 24 out of 132.
Comparison of analgesic requirement in both groups
Intra-peritoneal drain was removed on 2nd PO day in all 117 patients. In Group A 30 patients required PO analgesics, out of those 30 patients 15 had Intraperitoneal drain.
In Group A all patients with post-op Intra-peritoneal drain required analgesics & only 15 patients without drain required PO analgesics. On comparing study Group A with Group B for postoperative analgesics requirement, PO analgesic requirement was less in group A & "p" value was highly significant (p<0.05) at 4hr, 8hr in visceral, parietal, and also at 24 hr in shoulder pain After 24hr in visceral, parietal pain difference is not significant in group A and group B. The mean duration of surgery for all the patients analyzed was 78.08 minutes±18.77 SD. There was no significant difference between these two groups in relation to the duration of surgery. There was no significant difference in the postoperative hospital stay of the patients in both the groups. There was no major post-operative complication noted in any of Group. None of patients developed trocar site infection.
DISCUSSION
Pre-emptive analgesia is analgesia provided before a noxious stimulus and is type of treatment that reduces central and peripheral sensitizations which effectively reduce postoperative pain means preoperative administration of drugs that modulate the development of the nociception process in the intra and postoperative period, which results in a reduced postoperative requirement of painkillers. Postoperative pain after LC remains a major problem for the laparoscopic surgeon and anaesthesiologists. Now days many hospitals LC is performed as a day care procedure emphasizes the need for early and appropriate PO pain relief so that the patient has a painless discharge PO Bupivacaine a local anaesthetic agent use in this study for infiltration and intraperitoneal instillation both before and after removal of gall bladder because it is most commonly used in most of previous study.
A vial of 20 ml of 0.5% Bupivacaine is available at a cost of Rs.40. This cost is economically more demanding as compared to injection Tramadol which costs Rs 20 per dose. The peak serum level of intraperitoneal Bupivacaine is reached 20 to 30 min after application and lasts for 2 to 24 hours after surgery.
There are many scientific studies done in this field but the results are difficult to compare because of the varied clinical settings, different drugs and their dosages, application sites, comparators and pain outcomes reported. Demographic data across similar studies done Total patients evaluated in different studies ranged from 40 to 120. Female patients were more predominance in all the studies including the present study which is natural because of the high incidence of gall stone disease in female patients. Determining the sex incidence in any pain study is important because women report more pain than men. In this present study the mean age was 45 years. Most of the other patient details across all the comparable studies were similar. The mean operative time in our set up was on the higher side. Patients in our set up are from the poor socioeconomic background and also come from far flung villages, hence most of the patients have an extended hospital stay for social reasons and it was same in all the group of patients.
PO pain after LC is considered mainly from three sources. Incision sites on the abdominal wall causing parietal pain. Pneumoperitoneum associated with local (peritoneal and diaphragmatic stretching, ischaemia, acidosis) and systemic (hypercarbia causing sympathetic excitability resulting in amplification of local tissue inflammatory response) changes resulting in shoulder pain. Post cholecystectomy wound in the liver bed causing visceral pain.
Large group of patients" constituent of abdominal pain after LC arises from the incision sites (50-70%), pneumoperitoneum (20-30%), cholecystectomy (10-20%).
1,2
Some studies have diametrically gives an opposite view suggesting that visceral pain is predominant in the early PO phase after LC. 10 Parietal pain is less intense after LC due to small abdominal incisions and limited trauma to the abdominal wall. Shoulder tip pain which is insignificant in the early PO period increases to become the main complaint on the second day after lessening of the. 10 Shoulder tip pain is due to distension of peritoneal cavity by insufflated CO 2 causing diaphragmatic stretching temporary phrenic nerve neuropraxia, Loss of visceral surface tension due to creation of pneumoperitoneum leading to increase tension on the phrenohepatic ligaments, peritoneal trauma caused by chemical irritation, ischaemia and compression. We were meticulous in PO deflation after LC. This may partly explain the low incidence. The other possible theory could be the illiteracy level in our patients and a lack of understanding about shoulder pain.
Techniques of post cholecystectomy analgesia
There are many approaches has been tried with varying rates of success to diminish the intensity of post-operative pain after LC. These include low-pressure pneumoperitoneum, gasless technique for laparoscopy, local anaesthetic (LA) infiltration at trocar site, Saline washout of peritoneal cavity, instillation of the subdiaphragmatic region with a local anaesthetic, usually using bupivacaine, combined method of instillation of local anaesthetic drug in peritoneum and trocar site infiltration. [1] [2] [3] [4] [5] [6] [8] [9] [10] [11] [12] [13] [14] Instillation of intra-pleural bupivacaine after LC.
9-15 Use of conventional opioid and non-opioid analgesics in the postoperative period. were the highest at 4hrs and 8 hrs. Though Joris et al and Verma have concluded from their study that visceral pain is predominant we were unable to concur with them as both the scores were similar. The process of instillation of intra-peritoneal local anaesthetic (LA) drugs impact on the PO pain. They include timing of the intra-peritoneal administration of bupivacaine -"pre-emptive analgesia" before the dissection rather than at the end has been found to be more effective in some studies. 1, 3, 5 Pre emptive analgesia is preoperative administration of drugs that modulate the development of nociception process in the intra and postoperative periods resulting in reduced PO requirement of analgesics. Proper method of solution application by placing patient in Trendelenburg position to allow for dissemination of fluid beneath the diaphragm and gall bladder bed resulting in better analgesia. 1, 2 In this present study, we used Bupivacaine at the optimal dose 2 mg/kg to increase the contact time of Bupivacaine at the Gall Bladder bed and sub hepatic space before removal of gall bladder so as to increase absorption and get maximum post-operative pain relief which was compare with after removal of gall bladder. 
Role of intraperitoneal drain
Use of intra-peritoneal drain PO after LC leads to drainage of bupivacaine through the drain and increases post-operative analgesic requirement. In Group A 30 patients" required PO analgesics, of which 5 had postoperative intra-peritoneal drain. In Group B total 60 patients required PO analgesia out of which 24 patients had intraperitoneal drain. In both the group analgesic requirement was 100% in patients with drain. Use of intra-peritoneal drain may be ineffective in the control of visceral pain in such patients and lead to increase in postoperative analgesic requirement.
Role of bupivacaine infiltration at trocar sites
In the present study Bupivacaine 5 ml at each trocar site before skin incision infiltrated which significantly reduced the parietal pain at 4hr (36.74<52.26) and at 8hr (37.02<51.98) as compared to Group B in early postoperative period (p<0.05). Parietal pain comes near to the baseline within 24. These findings support the findings of two previous studies where local infiltration of Bupivacaine at its optimal dosage at trocar sites reduced parietal pain.
1,4,5

Analgesic requirement
Bupivacaine in pre-emptive form of administration with its optimal dose reduces the PO analgesic requirement as compared to postoperative group. About 60 patients (45%) from group B required analgesics within 8 hrs, as compared to 30 patients (22%) for Group A. There was a clinically significant decrease in the mean analgesic requirement in Group A as compared to the Group B.
Complication of drug
No local or intra-peritoneal complications were observed in our patients, which could be attributed to the study. The use of local anaesthetic drug (Bupivacaine), either intraperitoneal or trocar site infiltration in muscular fasciae at its optimal dose (2mg/kg), was found to be safe for use in our patients.
Limitations of the study
Instillation of Bupivacaine before creation of pneumoperitoneum is more difficult so there is not a absolute pre-emptive study. Although all surgeries followed a strict protocol, the patients were operated by a number of surgeons with varying experiences; hence minor variations in surgical technique may have been there. Though the patients were properly educated about VAS, some illiterate patients may not have adequately understood the instruction and accordingly in certain instances they may not have revealed their pain appropriately. 
CONCLUSION
Use of bupivacaine intraperitoneally at its optimal dosage (2 mg/kg) instilled in the gall bladder bed and sub diaphragmatic space before dissection of gall bladder in LC significantly reduces visceral as well as shoulder pain when compared with another group which use after removal of gall bladder. Use of bupivacaine (0.5%) infiltration at its optimal dosage (2 mg/kg) in the skin, subcutaneous tissue, muscular fasciae of trocar site before skin incision significantly reduces parietal pain in postoperative period compared to after removal of trocar in LC. When used at its optimal dose 2 mg/Kg, bupivacaine was found safe and easy to use without any adverse effects. Visceral pain, parietal pain, shoulder pain was predominant in early postoperative period after LC caused by surgical trauma at gall bladder bed and abdominal incision. Although instillation of bupivacaine before removal of gall bladder rather than after reduces the post-operative pain and analgesic and it is cost effective in patients from poor socioeconomic background in India.
